81 related articles for article (PubMed ID: 3623047)
1. [Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters].
Kühn W; Feichter GE; Hanke J; Rummel HH; Kaufmann M; Schmid H
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):446-51. PubMed ID: 3623047
[TBL] [Abstract][Full Text] [Related]
2. [Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma].
Schönborn I; Minguillon C; Reles A; Bartel U; Lichtenegger W
Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):357-64. PubMed ID: 8964450
[TBL] [Abstract][Full Text] [Related]
3. [Morphologic criteria of prognosis and clinical course in ovarian tumors of the borderline type].
Kühn W; Hanke J; Feichter GE; Rummel HH; Schmid H; Schmidt W; Kaufmann M
Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):173-8. PubMed ID: 3582924
[TBL] [Abstract][Full Text] [Related]
4. [Histologic classification and morphologic prognostic factors in malignant ovarian tumors].
Horn LC; Fricke K; Krugmann J
Zentralbl Gynakol; 1995; 117(7):335-45. PubMed ID: 7668062
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in stage I ovarian carcinoma.
Vergote I
Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of cell kinetic parameters of endometrial cancer].
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc.
Kuhn W; Schmalfeldt B; Reuning U; Pache L; Berger U; Ulm K; Harbeck N; Späthe K; Dettmar P; Höfler H; Jänicke F; Schmitt M; Graeff H
Br J Cancer; 1999 Apr; 79(11-12):1746-51. PubMed ID: 10206287
[TBL] [Abstract][Full Text] [Related]
9. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
11. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
12. Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
Wang PH; Yuan CC; Shyong WY; Chiang SC; Chao JY; Yen MS; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):220-5. PubMed ID: 10746418
[TBL] [Abstract][Full Text] [Related]
13. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
14. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
15. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of flow cytophotometric studies in ovarian cancer].
Volm M; Kleine W
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):456-9. PubMed ID: 3623048
[TBL] [Abstract][Full Text] [Related]
17. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
18. Lack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancer.
Coley HM; Sargent JM; Titley J; Taylor CG
Anticancer Res; 1999; 19(3A):2111-6. PubMed ID: 10470157
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
